Last reviewed · How we verify
Beta-lactam oral challenge — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Beta-lactam oral challenge (Beta-lactam oral challenge) — Meir Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Beta-lactam oral challenge TARGET | Beta-lactam oral challenge | Meir Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Beta-lactam oral challenge CI watch — RSS
- Beta-lactam oral challenge CI watch — Atom
- Beta-lactam oral challenge CI watch — JSON
- Beta-lactam oral challenge alone — RSS
Cite this brief
Drug Landscape (2026). Beta-lactam oral challenge — Competitive Intelligence Brief. https://druglandscape.com/ci/beta-lactam-oral-challenge. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab